+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Seborrheic Dermatitis Global Market Report 2024 - Product Thumbnail Image

Seborrheic Dermatitis Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
Anaphylaxis Treatment Global Market Report 2024 - Product Thumbnail Image

Anaphylaxis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
House Dust Mite Allergy Global Market Report 2024 - Product Thumbnail Image

House Dust Mite Allergy Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Ulcerative Colitis Global Market Report 2024 - Product Thumbnail Image

Ulcerative Colitis Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Chronic Lymphocytic Leukemia Treatment Global Market Report 2024 - Product Thumbnail Image

Chronic Lymphocytic Leukemia Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Urothelial Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
From
From
Glomerulonephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Glomerulonephritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Loading Indicator